clin360 Set to Change the Medical Research Study Game Permanently
The days of slow, disorganized clinical trials and isolated silos of information are finally over. clin360 is a new content management system (CMS) for the
healthcare market that will forever change the way we carry out and even think about clinical trials. The pharmaceutical industry, research organizations, and healthcare professionals alike are sure to appreciate the convenience and flexibility of this ingenious platform, which acts as a central hub for sites, doctors, CRAs, and anybody else involved - or even merely interested - in any particular trial. And more importantly, vital clinical trials involving potentially life-saving technology will proceed on a more timely basis.
Read more ...
Next generation allergy vaccines to be developed in Finland
VTT Ventures Oy has established a spin-off which develops next generation allergy vaccines. The spin-off is called Desentum Oy, and its operations are based on a VTT patented technology. Years of research, testing and official approval cycles are still required before the vaccines are ready for launch. VTT holds patents on gene technology which can be applied to alter the structure of an allergen, i.e. a protein causing allergy, so that it will cause less allergic symptoms than the original allergen, while remaining effective in desensitisation therapy.
Read more ...
Teva to use INFOTEHNA myPharmaExpert Suite as a global solution
Teva Pharmaceutical Industries Ltd. has approved INFOTEHNA's myPharmaExpertTM Suite in Teva Portfolio as a global solution. In next 15 months INFOTEHNA's solution will be rolled out to thousands of users in more than 10 global sites. Teva is the global leader in generic pharmaceuticals and a leading global supplier of active pharmaceutical ingredients (API), operating in 60 countries with 42,000 employees worldwide and the largest product portfolio in the industry.
Read more ...
Scientists discover 3 new gene faults which could increase melanoma risk by 30 percent
An international team of researchers has discovered the first DNA faults linked to melanoma - the deadliest skin cancer - that are not related to hair, skin or eye colour. Cancer Research UK scientists at the University of Leeds, together with a team from the GenoMEL consortium*, scanned the genes in blood samples from almost 3000 Europeans with melanoma, and compared these with samples taken from the general population. Their findings are published in Nature Genetics.**
Read more ...
Pale people may need vitamin D supplements
Researchers at the University of Leeds, funded by Cancer Research UK, suggest that people with very pale skin may be unable to spend enough time in the sun to make the amount of vitamin D the body needs - while also avoiding sunburn. The study, published in Cancer Causes and Control*, suggested that melanoma patients may need vitamin D supplements as well. But researchers also noted that sunlight and supplements are not the only factors that can determine the level of vitamin D in a person's body. Some inherited differences in the way people's bodies process vitamin D into the active form also have a strong effect on people's vitamin D levels.
Read more ...
MVA-B Spanish HIV vaccine shows 90 percent immune response in humans
Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with Gregorio Marañón Hospital in Madrid and Clínic Hospital in Barcelona, reveals MVA-B preventive vaccine's immune efficiency against Human's immunodeficiency virus (HIV). 90% of the volunteers who went through the tests developed an immunological response against the virus and 85% has kept this response for at least one year. Safety and efficiency of this treatment have been described in articles for Vaccine and Journal of Virology science magazines.
Read more ...
High Potential for the Immune and Antihypertensive Health Ingredients Market in Europe
The rising incidence of problems related to high blood pressure and weak immune system as well as the gravitation toward preventive healthcare is driving the European market for nutritional solutions in immune and antihypertensive health. The swine flu epidemic that hit Europe and the United States is one of the factors that boosted consumer interest in maintaining a healthy immune system.
Read more ...